Thursday, 11. March 2010

Life sciences


Advanced genomics and its applications for health



Combating major diseases



Specific support actions across thematic priority 1


Policy support

International co-operation

Reporting module


Aldo TAGLIABUE (»add to infobox)


Contact at
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL-ALTA SRL (ITE19 - Siena)


WORKED WITH (89/89) 

Luciano ADORINI (Contact / BIOXELL SPA (ITC45 - Milano) (IT - Italy))

Jose ALCAMI (Contact / INSTITUTO DE SALUD CARLOS III (ES300 - Madrid) (ES - Spain))

Marcello ALLEGRETTI (Contact / DOMPE' SPA (ITF11 - L'Aquila) (IT - Italy))

Peter ANDERSEN (Contact / STATENS SERUM INSTITUT (DK001 - København og Frederiksberg kommuner) (DK - Denmark))

Rot ANTAL (Contact / NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH (AT130 - Wien) (AT - Austria))

Oumou Y. BAH SOW (Contact / CHU IGNACE DEEN (GN - Guinea) (GN - Guinea))

Peer BORK (Contact / EUROPAISCHES LABORATORIUM FUER MOLEKULARBIOLOGIE - EMBL (DE125 - Heidelberg, Stadtkreis) (DE - Germany))

Soren BRUNAK (Contact / DANMARKS TEKNISKE UNIVERSITET (DK002 - Københavns amt) (DK - Denmark))

Fiorella CASAMENTI (Contact / UNIVERSITA DEGLI STUDI DI FIRENZE (ITE14 - Firenze) (IT - Italy))

Christophe COMBADIERE (Contact / UNIVERSITE PIERRE ET MARIE CURIE - PARIS VI (FR101 - Paris) (FR - France))

Giampietro CORRADIN (Contact / UNIVERSITE DE LAUSANNE (CH022 - Freiburg) (CH - Switzerland))

Nikos DEDES (Contact / EUROPEAN AIDS TREATMENT GROUP EV (DEA11 - Düsseldorf, Kreisfreie Stadt) (DE - Germany))

Gianfranco DEL PRETE (Contact / UNIVERSITA DEGLI STUDI DI FIRENZE (ITE14 - Firenze) (IT - Italy))

Diego DI LORENZO (Contact / AZIENDA OSPEDALIERA "SPEDALI CIVILI" DI BRESCIA (ITC47 - Brescia) (IT - Italy))

Francesco DIELI (Contact / CONSIGLIO NAZIONALE DELLE RICERCHE (ITE43 - Roma) (IT - Italy))

Gordon DOUGAN (Contact / IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE (UKI11 - Inner London - West) (UK - Great Britain))

Dominique EMILIE (Contact / INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR101 - Paris) (FR - France))

Barbara ENSOLI (Contact / ISTITUTO SUPERIORE DI SANITA (ITE43 - Roma) (IT - Italy))

Eva Maria FENYO (Contact / LUNDS UNIVERSITET (SE044 - Skåne län) (SE - Sweden))

Richard FRY (Contact / CELLON SA (LU000 - Luxembourg (Grand-Duché)) (LU - Luxemburg))

Andrzej GLABINSKI (Contact / UNIVERSYTET MEDYCZNY W LODZI (PL113 - Miasto Lodz) (PL - Poland))

Frances GOTCH (Contact / IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE (UKI11 - Inner London - West) (UK - Great Britain))

Manfred HENNECKE (Contact / BERTHOLD TECHNOLOGIES GMBH & CO KG (DE12A - Calw) (DE - Germany))

Harvey HOLMES (Contact / NATIONAL BIOLOGICAL STANDARDS BOARD (UKH23 - Hertfordshire) (UK - Great Britain))

Jan HOLMGREN (Contact / GOETEBORGS UNIVERSITET (SE0A2 - Västra Götalands län) (SE - Sweden))

Vicky JESPERS (Contact / PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE (BE211 - Arr. Antwerpen) (BE - Belgium))

Eduard Vladimirovich KARAMOV (Contact / RUSSIAN ACADEMY OF MEDICAL SCIENCES (RU - Russia) (RU - Russia))

Stefan H. E. KAUFMANN (Contact / MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV (DE212 - München, Kreisfreie Stadt) (DE - Germany))

Charles KELLY (Contact / KING'S COLLEGE LONDON (UKI11 - Inner London - West) (UK - Great Britain))

Paolo LA COLLA (Contact / UNIVERSITA DEGLI STUDI DI CAGLIARI (ITG2 - Sardegna) (IT - Italy))

Charles LACEY (Contact / UNIVERSITY OF YORK (UKE21 - York) (UK - Great Britain))

Jean-Francois LAES (Contact / DNA VISION SA (BE322 - Arr. Charleroi) (BE - Belgium))

Antonio LANZAVECCHIA (Contact / ISTUTO DI RICERCA IN BIOMEDICINA (CH070 - Ticino) (CH - Switzerland))

Roger LE GRAND (Contact / COMMISSARIAT A L'ENERGIE ATOMIQUE (CEA) (FR101 - Paris) (FR - France))

Thomas LEHNER (Contact / KING'S COLLEGE LONDON (UKI11 - Inner London - West) (UK - Great Britain))

Geert LEROUX-ROELS (Contact / UNIVERSITEIT GENT (BE234 - Arr. Gent) (BE - Belgium))

David John Murdoch LEWIS (Contact / ST GEORGE'S HOSPITAL MEDICAL SCHOOL (UKI11 - Inner London - West) (UK - Great Britain))

Martin LIPP (Contact / MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN (DE300 - Berlin) (DE - Germany))

Adriana Caterina MAGGI (Contact / UNIVERSITA DEGLI STUDI DI MILANO (ITC45 - Milano) (IT - Italy))

Alberto MANTOVANI (Contact / ISTITUTO DI RICERCHE FARMACOLOGICHE "MARIO NEGRI" (ITC45 - Milano) (IT - Italy))

Philip MARSH (Contact / HEALTH PROTECTION AGENCY (UKI11 - Inner London - West) (UK - Great Britain))

Carlos MARTINEZ-A (Contact / CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES300 - Madrid) (ES - Spain))

Sheena MCCORMACK (Contact / MEDICAL RESEARCH COUNCIL (UKI11 - Inner London - West) (UK - Great Britain))

Eunan MCGLINCHEY (Contact / ARCHPORT LIMITED (IE021 - Dublin) (IE - Ireland))

Donata MEDAGLINI (Contact / UNIVERSITA DEGLI STUDI DI SIENA (ITE19 - Siena) (IT - Italy))

Kingston MILLS (Contact / THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELISABETH NEAR DUBLIN (IE021 - Dublin) (IE - Ireland))

Christiane MOOG (Contact / UNIVERSITE LOUIS PASTEUR (FR421 - Bas-Rhin) (FR - France))

Bernhard MOSER (Contact / UNIVERSITAET BERN (CH033 - Aargau) (CH - Switzerland))

Peter NELSON (Contact / LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE212 - München, Kreisfreie Stadt) (DE - Germany))

Kopek NIHLMARK (Contact / MABTECH AB (SE010 - Stockholms län) (SE - Sweden))

Stephen NORLEY (Contact / ROBERT KOCH-INSTITUT (DE300 - Berlin) (DE - Germany))

Eizenberg ORLY (Contact / BIOKINE THERAPEUTICS LTD (IL - Israel) (IL - Israel))

Marc PARMENTIER (Contact / UNIVERSITE LIBRE DE BRUXELLES (BE100 - Arr. de Bruxelles-Capitale) (BE - Belgium))

Costantino PITZALIS (Contact / KING'S COLLEGE LONDON (UKI11 - Inner London - West) (UK - Great Britain))

Gianni POZZI (Contact / UNIVERSITA DEGLI STUDI DI SIENA (ITE19 - Siena) (IT - Italy))

Amanda E. I. PROUDFOOT (Contact / SERONO INTERNATIONAL SA (CH012 - Valais) (CH - Switzerland))

Paul RACZ (Contact / BERNHARD-NOCHT-INSTITUT FUR TROPENMEDIZIN (DE600 - Hamburg) (DE - Germany))

Rino RAPPUOLI (Contact / NOVARTIS VACCINES AND DIAGNOSTICS SRL (ITE19 - Siena) (IT - Italy))

Juha RINNE (Contact / TURUN YLIOPISTO (FI183 - Varsinais-Suomi) (FI - Finland))

Sergio ROMAGNANI (Contact / UNIVERSITA DEGLI STUDI DI FIRENZE (ITE14 - Firenze) (IT - Italy))

Annemieke J. M. ROZEMULLER (Contact / VRIJE UNIVERSITEIT MEDISCH CENTRUM (NL326 - Groot-Amsterdam) (NL - Netherlands))

Johanna Maria ROZEMULLER (Contact / ACADEMIC MEDICAL CENTRE BY THE UNIVERSITY OF AMSTERDAM (NL326 - Groot-Amsterdam) (NL - Netherlands))

Quentin SATTENTAU (Contact / THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (UKJ14 - Oxfordshire) (UK - Great Britain))

Giuseppe SCALA (Contact / UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II (ITF33 - Napoli) (IT - Italy))

Gabriella SCARLATTI (Contact / FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR (ITC45 - Milano) (IT - Italy))

Hanneke SCHUITEMAKER (Contact / STICHTING SANQUIN BLOEDVOORZIENING (NL326 - Groot-Amsterdam) (NL - Netherlands))

Thue W. SCHWARTZ (Contact / KOBENHAVNS UNIVERSITET (DK001 - København og Frederiksberg kommuner) (DK - Denmark))

Peter SEBO (Contact / ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ010 - Hlavni mesto Praha) (CZ - Czech Republic))

Robin SHATTOCK (Contact / ST GEORGE'S HOSPITAL MEDICAL SCHOOL (UKI11 - Inner London - West) (UK - Great Britain))

Christiane STAHL-HENNIG (Contact / DEUTSCHES PRIMATENZENTRUM GMBH (DE915 - Göttingen) (DE - Germany))

Gabriela STIEGLER (Contact / POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSHUNGS GMBH (AT130 - Wien) (AT - Austria))

Frederic TANGY (Contact / INSTITUT PASTEUR (FR101 - Paris) (FR - France))

Georg C. TERSTAPPEN (Contact / SIENA BIOTECH SPA (ITE19 - Siena) (IT - Italy))

Andreas THIEL (Contact / DEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN (DE300 - Berlin) (DE - Germany))

Paul TOMKINS (Contact / ATHLONE INSTITUTE OF TECHNOLOGY (IE013 - West) (IE - Ireland))

Mariagrazia UGUCCIONI (Contact / ISTUTO DI RICERCA IN BIOMEDICINA (CH070 - Ticino) (CH - Switzerland))

Mikko Tapani UNKILA (Contact / HORMOS MEDICAL OYI (FI183 - Varsinais-Suomi) (FI - Finland))

Jozef VAN DAMME (Contact / KATHOLIEKE UNIVERSITEIT LEUVEN (BE242 - Arr. Leuven) (BE - Belgium))

Bernard VERRIER (Contact / CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR101 - Paris) (FR - France))

Gerald VOSS (Contact / GLAXOSMITHKLINE BIOLOGICALS SA (BE310 - Arr. Nivelles) (BE - Belgium))

Jan Wim VRIJBLOED (Contact / POLYPHOR (CH056 - Graubünden) (CH - Switzerland))

Kalervo VÄÄNÄNEN (Contact / TURUN YLIOPISTO (FI183 - Varsinais-Suomi) (FI - Finland))

Britta WAHREN (Contact / KAROLINSKA INSTITUTET (SE010 - Stockholms län) (SE - Sweden))

Andrew WARD (Contact / UNIVERSITY OF BATH (UKK12 - North and North East Somerset, South Gloucestershire) (UK - Great Britain))

Robin A. WEISS (Contact / UNIVERSITY COLLEGE LONDON (UKI11 - Inner London - West) (UK - Great Britain))

Timothy J. WILLIAMS (Contact / IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE (UKI11 - Inner London - West) (UK - Great Britain))

Nathalie WINTER (Contact / INSTITUT PASTEUR (FR101 - Paris) (FR - France))

Klaus ÜBERLA (Contact / RUHR-UNIVERSITAET BOCHUM (DEA51 - Bochum, Kreisfreie Stadt) (DE - Germany))

Donato ZIPETO (Contact / UNIVERSITA DEGLI STUDI DI VERONA (ITD31 - Verona) (IT - Italy))

RELATED PROJECTS (6/6) 

ADIT - Design of small molecule therapeutics for the treatment of Alzheimer's disease on the discovery of innovative drug targets.' (Life sciences, genomics and biotechnology for health)

EXERA - Development of 3D in vitro models of estrogen-reporter mouse tissues for the pharmaco-toxicological analysis of nuclear receptors-interacting compounds (NR-ICs) (Life sciences, genomics and biotechnology for health)

EUROPRISE - European Vaccine and Microbicides Enterprise (Life sciences, genomics and biotechnology for health)

INNOCHEM - Innovative Chemokine-based Therapeutic Strategies for Autoimmunity and Chronic Inflammation (Life sciences, genomics and biotechnology for health)

MUVAPRED - Mucosal Vaccines for Poverty Related Diseases (Life sciences, genomics and biotechnology for health)

REBAVAC - Novel opportunities to develop vaccines to control anti-bacterial resistant encapsulated bacteria: from the trials back to the laboratory. The Reverse Clinical Vaccinology approach (Life sciences, genomics and biotechnology for health)




SEARCH



»Advanced Search



SHORT CUTS

»Thematic areas

»Organisations

»Persons



LAST PAGES (3/23) show all
»
Person: Patrik RORSMAN
»
Project: Validation of recently developed diagnostic and prognostic markers and identification of novel markers for prostate cancer using European databases
»
Person: Clara CAMASCHELLA


INFOBOX (0/0) show all
Your infobox is empty


LifeCompetence is operated by AVEDAS.
LifeCompetence operated by AVEDAS
Contact: support@avedas.com


STOCKHOLM-UPPSALA LIFE SCIENCE
Powered by CONVERIS 2.0